The cystatin M/E-controlled pathway of skin barrier formation: expression of its key components in psoriasis and atopic dermatitis

被引:27
作者
Cheng, T. [1 ]
Tjabringa, G. S. [1 ]
van Vlijmen-Willems, I. M. J. J. [1 ]
Hitomi, K. [2 ]
van Erp, P. E. J. [1 ]
Schalkwijk, J. [1 ]
Zeeuwen, P. L. J. M. [1 ]
机构
[1] Radboud Univ Nijmegen, Med Ctr, Dept Dermatol, Nijmegen Ctr Mol Life Sci, NL-6500 HB Nijmegen, Netherlands
[2] Nagoya Univ, Dept Appl Mol Biosci, Grad Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan
关键词
atopic dermatitis; cystatin M; E; epidermis; proteases; psoriasis; reconstructed skin; CYSTEINE PROTEINASE-INHIBITOR; HAIR FOLLICLE MORPHOGENESIS; HUMAN CATHEPSIN V; EPIDERMAL DIFFERENTIATION; SUSCEPTIBILITY LOCUS; GENE-EXPRESSION; DEFICIENT MICE; TRANSGLUTAMINASE; KERATINOCYTES; PROTEASE;
D O I
10.1111/j.1365-2133.2009.09156.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background The antiprotease activity of cystatin M/E regulates skin barrier formation, as it inhibits the activity of cathepsin V, cathepsin L and legumain, thereby controlling the processing of transglutaminase 3. Misregulation of this pathway by unrestrained protease activity, as seen in cystatin M/E-deficient mice, leads to abnormal stratum corneum and hair follicle formation, and severe disturbance of skin barrier function. Objectives Our major aim was to make a quantitative analysis of the expression of all players of this pathway in the epidermis of patients with inflammatory skin diseases. A second aim was to determine if reconstructed human skin could be used as an in vitro model system to investigate this pathway. Methods Autopsy material from normal human tissues, biopsies from normal skin of healthy volunteers, and lesional skin from patients with atopic dermatitis and psoriasis were used to study the expression of the above-mentioned molecules at the mRNA level by quantitative real-time polymerase chain reaction. Localization of the protein was performed by immunofluorescence microscopy, and expression was quantitated by image analysis. Results In skin, cystatin M/E is expressed at relatively higher levels than its target proteases, when compared with other tissues, which emphasizes its prominent role in cutaneous biology. We found decreased expression of cystatin M/E and cathepsin V in lesional atopic dermatitis and psoriasis epidermis at the mRNA level as well as the protein level. Cathepsin L and transglutaminase 3 were increased at the transcriptional level; however, this was not reflected by higher protein levels. Interestingly, the expression of all these molecules in reconstructed skin was qualitatively and quantitatively similar to the in vivo situation. Conclusions Disturbance of the cystatin M/E - cathepsin pathway could contribute to the dysregulated skin barrier function observed in inflammatory dermatoses. Human reconstructed skin appears to be a valuable model to study this novel biochemical pathway in vitro.
引用
收藏
页码:253 / 264
页数:12
相关论文
共 52 条
  • [1] Adachi W, 1998, INVEST OPHTH VIS SCI, V39, P1789
  • [2] Three-dimensional structure of the human transglutaminase 3 enzyme: binding of calcium ions changes structure for activation
    Ahvazi, B
    Kim, HC
    Kee, SH
    Nemes, Z
    Steinert, PM
    [J]. EMBO JOURNAL, 2002, 21 (09) : 2055 - 2067
  • [3] Autosomal recessive ichthyosis with hypotrichosis caused by a mutation in ST14, encoding type II transmembrane serine protease matriptase
    Basel-Vanagaite, Lina
    Attia, Revital
    Ishida-Yamamoto, Akemi
    Rainshtein, Limor
    Ben Amitai, Dan
    Lurie, Raziel
    Pasmanik-Chor, Metsada
    Indelman, Margarita
    Zvulunov, Alex
    Saban, Shirley
    Magal, Nurit
    Sprecher, Eli
    Shohat, Mordechai
    [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 2007, 80 (03) : 467 - 477
  • [4] Impaired hair follicle morphogenesis and cycling with abnormal epidermal differentiation in nackt mice, a cathepsin L-deficient mutation
    Benavides, F
    Starost, MF
    Flores, M
    Gimenez-Conti, IB
    Guénet, JL
    Conti, CJ
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 2002, 161 (02) : 693 - 703
  • [5] Insights into psoriasis and other inflammatory diseases from large-scale gene expression studies
    Bowcock, AM
    Shannon, W
    Du, FH
    Duncan, J
    Cao, K
    Aftergut, K
    Catier, J
    Fernandez-Vina, MA
    Menter, A
    [J]. HUMAN MOLECULAR GENETICS, 2001, 10 (17) : 1793 - 1805
  • [6] Human cathepsin V functional expression, tissue distribution, electrostatic surface potential, enzymatic characterization, and chromosomal localization
    Brömme, D
    Li, ZQ
    Barnes, M
    Mehler, E
    [J]. BIOCHEMISTRY, 1999, 38 (08) : 2377 - 2385
  • [7] Expression of cathepsin L and its inhibitor hurpin in inflammatory and neoplastic skin diseases
    Bylaite, M
    Moussali, H
    Marciukaitiene, I
    Ruzicka, T
    Walz, M
    [J]. EXPERIMENTAL DERMATOLOGY, 2006, 15 (02) : 110 - 118
  • [8] Mutations in SPINK5, encoding a serine protease inhibitor, cause Netherton syndrome
    Chavanas, S
    Bodemer, C
    Rochat, A
    Hamel-Teillac, D
    Ali, M
    Irvine, AD
    Bonafé, JL
    Wilkinson, J
    Taïeb, A
    Barrandon, Y
    Harper, JI
    de Prost, Y
    Hovnanian, A
    [J]. NATURE GENETICS, 2000, 25 (02) : 141 - 142
  • [9] Response of keratinocytes from normal and psoriatic epidermis to interferon-γ differs in the expression of zinc-α2-glycoprotein and cathepsin D
    Chen, SH
    Arany, I
    Apisarnthanarax, N
    Rajaraman, S
    Tyring, SK
    Horikoshi, T
    Brysk, H
    Brysk, MM
    [J]. FASEB JOURNAL, 2000, 14 (03) : 565 - 571
  • [10] CHENG T, J INVEST DE IN PRESS